|
|
| (One intermediate revision by the same user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Metoprolol succinate#Drug Interactions]] |
| {{Metoprolol}}
| |
| {{CMG}}
| |
| | |
| ====Catecholamine Depleting Drugs====
| |
| | |
| [[Catecholamine]] depleting drugs (eg, [[reserpine]], [[MAO inhibitor|monoamine oxidase (MAO) inhibitors]]) may have an additive effect when given with [[beta-blocking agent]]s. Observe patients treated with TOPROL-XL plus a [[catecholamine]] depletor for evidence of [[hypotension]] or marked [[bradycardia]], which may produce [[vertigo]], [[syncope]], or [[postural hypotension]]. | |
| | |
| ====CYP2D6 Inhibitors====
| |
| | |
| Drugs that inhibit [[CYP2D6]] such as [[quinidine]], [[fluoxetine]], [[paroxetine]], and [[propafenone]] are likely to increase metoprolol concentration. In healthy subjects with [[CYP2D6]] extensive metabolizer phenotype, coadministration of [[quinidine]] 100 mg and immediate-release metoprolol 200 mg tripled the concentration of S-metoprolol and doubled the metoprolol elimination half-life. In four patients with cardiovascular disease, coadministration of [[propafenone]] 150 mg t.i.d. with immediate-release metoprolol 50 mg t.i.d. resulted in two- to five-fold increases in the steady-state concentration of metoprolol. These increases in plasma concentration would decrease the cardioselectivity of metoprolol.
| |
| | |
| ====Digitalis, Clonidine, and Calcium Channel Blockers====
| |
| | |
| [[Digitalis glycosides]], [[clonidine]], [[diltiazem]] and [[verapamil]] slow atrioventricular conduction and decrease [[heart rate]]. Concomitant use with [[beta blocker]]s can increase the risk of [[bradycardia]].
| |
| | |
| If [[clonidine]] and a [[beta blocker]], such as metoprolol are coadministered, withdraw the [[beta-blocker]] several days before the gradual withdrawal of [[clonidine]] because [[beta-blocker]]s may exacerbate the [[rebound hypertension]] that can follow the [[withdrawal]] of [[clonidine]]. If replacing [[clonidine]] by [[beta-blocker]] therapy, delay the introduction of [[beta-blocker]]s for several days after [[clonidine]] administration has stopped ''[see [[Toprol XL warnings and precautions|Warnings and Precautions]]]''.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TOPROL XL (METOPROLOL SUCCINATE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01038198-b4f0-41f3-9a9c-5c84e5a0d3b9 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Beta blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |